CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病

Abstract

Recommended Article

Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis When, where, and how to target vascular inflammation in the post-CANTOS era? Plaque Rupture, compared to Plaque Erosion, is associated with Higher Level of Pan-coronary Inflammation Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic? 2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)

Original Research2021 Mar 25;12(1):1889.

JOURNAL:Nat Commun. Article Link

Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis

A Alabi, XD Xia, DW Zhang et al. Keywords: LDL receptor; soluble ectodomain; proteinase responsible for LDLR cleavage

Full Text PDF